Hematology

Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe subtype of acute myeloid leukemia…

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at preventing heart damage caused by…

Joshua Richter – Associate Professor, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. What initially…

Children with ALL who are overweight or obese at multiple points during treatment have worse survival rates and higher relapse risk, according to a cohort study of 794 patients.

A new cohort study analysing over 100,000 A&E visits in North Carolina has redefined what constitutes high emergency care use among people with sickle cell disease.

A large-scale US study reveals that 34% of sickle cell disease patients are readmitted within 30 days of hospital discharge, nearly triple the rate of non-SCD patients.

In a major study presented at EHA, Noella Collado-Gisbert demonstrated that residual disease kinetics are a strong predictor of survival in multiple myeloma.